1. |
Wilder-Smith EP, Lim EC, Teoh HL, et al. The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity. Ann Acad Med Singapore, 2005, 34(7): 417-420.
|
2. |
Baxter P, Clarke A, Cross H, et al. Idiopathic catastrophic epileptic encephalopathy presenting with acute onset intractable status. Seizure, 2003, 12(6): 379-387.
|
3. |
van Baalen A, Häusler M, Boor R, et al. Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood. Epilepsia, 2010, 51(7): 1323-1328.
|
4. |
Sakuma H, Awaya Y, Shiomi M, et al. Acute encephalitis with refractory, repetitive partial seizures (AERRPS): a peculiar form of childhood encephalitis. Acta Neurol Scand, 2010, 121(4): 251-256.
|
5. |
Mikaeloff Y, Jambaque I, Hertz-Pannier L, et al. Devastating epileptic encephalopathy in school-aged children (DESC): a pseudo encephalitis. Epilepsy Res, 2006, 69(1): 67-79.
|
6. |
Hirsch LJ, Gaspard N, van Baalen A, et al. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia, 2018, 59(4): 739-744.
|
7. |
Nabbout R, Vezzani A, Dulac O, Chiron C. Acute encephalopathy with inflammation-mediated status epilepticus. Lancet Neurol, 2011, 10(1): 99-108.
|
8. |
Sakuma H, Tanuma N, Kuki I, et al. Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus. J Neurol Neurosurg Psychiatry, 2015, 86(7): 820-822.
|
9. |
Juhász C, Buth A, Chugani DC, et al. Successful surgical treatment of an inflammatory lesion associated with new-onset refractory status epilepticus. Neurosurg Focus, 2013, 34(6): E5.
|
10. |
Vezzani A, Balosso S, Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun, 2008, 22(6): 797-803.
|
11. |
Gall CR, Jumma O, Mohanraj R. Five cases of new onset refractory status epilepticus (NORSE) syndrome: outcomes with early immunotherapy. Seizure, 2013, 22(3): 217-220.
|
12. |
Khawaja AM, DeWolfe JL, Miller DW, et al. New-onset refractory status epilepticus (NORSE)−The potential role for immunotherapy. Epilepsy Behav, 2015, 47: 17-23.
|
13. |
Gaspard N, Foreman BP, Alvarez V, et al. New-onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology, 2015, 85(18): 1604-1613.
|
14. |
Iizuka T, Kanazawa N, Kaneko J, et al. Cryptogenic NORSE: Its distinctive clinical features and response to immunotherapy. Neurol Neuroimmunol Neuroinflamm, 2017, 4(6): e396.
|
15. |
Costello DJ, Kilbride RD, Cole AJ. Cryptogenic new onset refractory status epilepticus (NORSE) in adults-infectious or not. J Neurol Sci, 2009, 277(1-2): 26-31.
|
16. |
Meletti S, Giovannini G, d’Orsi G, et al. New-onset refractory status epilepticus with claustrum damage: definition of the clinical and neuroimaging features. Front Neurol, 2017, 8: 111.
|
17. |
De Keyser J. Status epilepticus with neuron-reactive serum antibodies: response to plasma exchange. Neurology, 2000, 55(9): 1421.
|
18. |
王学峰, 王康, 肖波. 成人全面性惊厥性癫痫持续状态治疗中国专家共识. 国际神经病学神经外科学杂志, 2018, 45(01): 1-4.
|
19. |
中华医学会神经病学分会脑电图与癫痫学组. 非惊厥性癫痫持续状态的治疗专家共识. 中华神经科杂志, 2013, 46(2): 133-137.
|
20. |
Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus−Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia, 2015, 56(10): 1515-1523.
|
21. |
Van Lierde I, Van Paesschen W, Dupont P, et al. De novo cryptogenic refractory multifocal febrile status epilepticus in the young adult: a review of six cases. Acta Neurol Belg, 2003, 103(2): 88-94.
|
22. |
Li J, Saldivar C, Maganti RK. Plasma exchange in cryptogenic new onset refractory status epilepticus. Seizure, 2013, 22(1): 70-73.
|
23. |
Gaspard N, Hirsch LJ, Sculier C, et al. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): state of the art and perspectives. Epilepsia, 2018, 59(4): 745-752.
|